FY 2025 revenue guidance was increased to $2.945 billion to $2.975 billion, from the previous range of $2.875 billion to $2.905 billion, factoring in currency adjustments. The company maintained its ...

MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

A global modeling study found that 8,500 tonnes of antibiotics from human use alone enter rivers annually, threatening ...

Morepen Laboratories targets ₹1,000 crore in 5 years with new products, research-led therapies, and global sales growth.

Emzor Reaffirms Commitment To Eradicating Malaria In Nigeria, AfricaAhead of the World Malaria Day 2025, Emzor Pharmaceutical Industries Limited, a leading firm in Nigeria’s pharmaceutical sector, ...

The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond.

The White House has hinted that its first trade deal could be with South Korea, saying that the talks are progressing faster ...

Trump’s onslaught has been relentless, and no one is safe. If legal residents – immigrants and students – protected by the ...

Besides generics, Dr. Reddy’s has committed a lot of resources to develop its biosimilars as well as new chemical entity business. Biosimilars have been seen as a growth engine for large, capable ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...

The deal for the San Diego hub provides the CDMO with its first-ever North American manufacturing location for prefilled syringes and cartridges.